Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion

British Journal of Pharmacology

Volumn 161, Issue 1, 2010, Pages 33-50

  Wu, X ^a   Kihara, T ^a   Hongo, H ^a   Akaike, A ^a   Niidome, T ^a   Sugimoto, H ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

astrocyte; AT 1 receptor; GLT 1; ischaemia; OGD; stroke

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; GLUCOSE; GLUTAMIC ACID; LACTATE DEHYDROGENASE; LOSARTAN; MESSENGER RNA; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; NITRIC OXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TELMISARTAN; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; BRAIN ISCHEMIA; CELL CULTURE; CELL DAMAGE; COCULTURE; CONTROLLED STUDY; DEPLETION; ENZYME RELEASE; FEMALE; IMMUNOBLOTTING; IN VITRO STUDY; NERVE CELL; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OXYGEN GLUCOSE DEPLETION; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ASTROCYTES; BENZIMIDAZOLES; BENZOATES; BIPHENYL COMPOUNDS; CELL DEATH; COCULTURE TECHNIQUES; EXCITATORY AMINO ACID TRANSPORTER 2; GENE EXPRESSION REGULATION; GLUCOSE; GLUTAMIC ACID; IMIDAZOLES; LOSARTAN; NEURONS; NITRIC OXIDE; OXYGEN; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RNA, MESSENGER;

EID: 77955777876     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00840.x     Document Type: Article

References (57)

1. AbdAlla S, Lother H, el Missiry A, Langer A, Sergeev P, el Faramawy Y et al. (2009a). Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. J Biol Chem 284 : 6554 6565.
2. AbdAlla S, Lother H, el Missiry A, Sergeev P, Langer A, el Faramawy Y et al. (2009b). Dominant negative AT2 receptor oligomers induce G-protein arrest and symptoms of neurodegeneration. J Biol Chem 284 : 6566 6574.
3. Alexander SPH, Mathie A, Peters JA (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254.
4. Beal M (1992). Mechanisms of excitotoxicity in neurologic diseases. FASEB J 6 : 3338 3344.
5. Beart P, O'Shea R (2007). Transporters for l-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150 : 5 17.
6. Danbolt N (2001). Glutamate uptake. Prog Neurobiol 65 : 1 105.
7. Dávalos A, Castillo J, Serena J, Noya M (1997). Duration of glutamate release after acute ischemic stroke. Stroke 28 : 708 710.
8. Donnan G, Fisher M, Macleod M, Davis S (2008). Stroke. Lancet 371 : 1612 1623.
9. Dzau V, Ingelfinger J, Pratt R, Ellison K (1986). Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains. Hypertension 8 : 544 548.
10. Furuta A, Rothstein J, Martin L (1997). Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J Neurosci 17 : 8363 8375.
11. de Gasparo M, Catt K, Inagami T, Wright J, Unger T (2000). International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52 : 415 472.
12. Grewal J, Luttrell L, Raymond J (2001). G protein-coupled receptors desensitize and down-regulate epidermal growth factor receptors in renal mesangial cells. J Biol Chem 276 : 27335 27344.
13. Gyurko R, Wielbo D, Phillips M (1993). Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept 49 : 167 174.
14. Inaba S, Iwai M, Tomono Y, Senba I, Furuno M, Kanno H et al. (2009). Exaggeration of focal cerebral ischemia in transgenic mice carrying human renin and human angiotensinogen genes. Stroke 40 : 597 603.
15. Ingram E, Wiseman J, Tessler S, Emson P (2001). Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse. J Neurochem 79 : 564 575.
16. Joglar B, Rodriguez-Pallares J, Rodriguez-Perez A, Rey P, Guerra M, Labandeira-Garcia J (2009). The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease. J Neurochem 109 : 656 669.
17. Kagiyama T, Kagiyama S, Phillips M (2003). Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats. Regul Pept 110 : 241 247.
18. Kawahara K, Kosugi T, Tanaka M, Nakajima T, Yamada T (2005). Reversed operation of glutamate transporter GLT-1 is crucial to the development of preconditioning-induced ischemic tolerance of neurons in neuron/astrocyte co-cultures. Glia 49 : 349 359.
19. Kehoe P, Miners S, Love S (2009). Angiotensins in Alzheimer's disease - friend or foe? Trends Neurosci 32 : 619 628.
20. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H et al. (1997). Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann Neurol 42 : 159 163.
21. Kurihara T, Ozawa Y, Nagai N, Shinoda K, Noda K, Imamura Y et al. (2008). Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 57 : 2191 2198.
22. Lepore A, Rauck B, Dejea C, Pardo A, Rao M, Rothstein J et al. (2008). Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 11 : 1294 1301.
23. Li J, Culman J, Hörtnagl H, Zhao Y, Gerova N, Timm M et al. (2005). Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 19 : 617 619.
24. Liévens J, Woodman B, Mahal A, Spasic-Boscovic O, Samuel D, Kerkerian-Le Goff L et al. (2001). Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis 8 : 807 821.
25. Lin C, Bristol L, Jin L, Dykes-Hoberg M, Crawford T, Clawson L et al. (1998). Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20 : 589 602. (Pubitemid 28153087)
26. Lo E, Dalkara T, Moskowitz M (2003). Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4 : 399 415.
27. Lu D, Yu K, Raizada M (1995). Retrovirus-mediated transfer of an angiotensin type I receptor (AT1-R) antisense sequence decreases AT1-Rs and angiotensin II action in astroglial and neuronal cells in primary cultures from the brain. Proc Natl Acad Sci USA 92 : 1162 1166.
28. Maeda K, Hata R, Bader M, Walther T, Hossmann K (1999). Larger anastomoses in angiotensinogen-knockout mice attenuate early metabolic disturbances after middle cerebral artery occlusion. J Cereb Blood Flow Metab 19 : 1092 1098. (Pubitemid 30167759)
29. Miller S, Romano C, Cotman C (1995). Growth factor upregulation of a phosphoinositide-coupled metabotropic glutamate receptor in cortical astrocytes. J Neurosci 15 : 6103 6109.
30. 2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J Immunol Methods 202 : 133 141.
31. Münch C, Penndorf A, Schwalenstöcker B, Troost D, Ludolph A, Ince P et al. (2001). Impaired RNA splicing of 5′-regulatory sequences of the astroglial glutamate transporter EAAT2 in human astrocytoma. J Neurol Neurosurg Psychiatry 71 : 675 678.
32. Nakagawa T, Otsubo Y, Yatani Y, Shirakawa H, Kaneko S (2008). Mechanisms of substrate transport-induced clustering of a glial glutamate transporter GLT-1 in astroglial-neuronal cultures. Eur J Neurosci 28 : 1719 1730.
33. Paulson O, Waldemar G, Andersen A, Barry D, Pedersen E, Schmidt J et al. (1988). Role of angiotensin in autoregulation of cerebral blood flow. Circulation 77 (6 Pt 2 I55 I58.
34. Peacey E, Miller C, Dunlop J, Rattray M (2009). The four major N- and C-terminal splice variants of the excitatory amino acid transporter GLT-1 form cell surface homomeric and heteromeric assemblies. Mol Pharmacol 75 : 1062 1073.
35. Perlman S, Schambye H, Rivero R, Greenlee W, Hjorth S, Schwartz T (1995). Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor. J Biol Chem 270 : 1493 1496.
36. Phillips M (1987). Functions of angiotensin in the central nervous system. Annu Rev Physiol 49 : 413 435.
37. Ramser J, Abidi F, Burckle C, Lenski C, Toriello H, Wen G et al. (2005). A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet 14 : 1019 1027.
38. Romera C, Hurtado O, Mallolas J, Pereira M, Morales J, Romera A et al. (2007). Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J Cereb Blood Flow Metab 27 : 1327 1338.
39. Rossi D, Brady J, Mohr C (2007). Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 10 : 1377 1386.
40. Rothstein J, Dykes-Hoberg M, Pardo C, Bristol L, Jin L, Kuncl R et al. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16 : 675 686.
41. Rothstein J, Patel S, Regan M, Haenggeli C, Huang Y, Bergles D et al. (2005). Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433 : 73 77.
42. Sasaki K, Shimura H, Itaya M, Tanaka R, Mori H, Mizuno Y et al. (2009). Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains. FEBS Lett 583 : 2194 2200.
43. Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J et al. (2003). The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34 : 1699 1703.
44. Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J et al. (2005). Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 36 : 1218 1226.
45. Sheldon A, González M, Krizman-Genda E, Susarla B, Robinson M (2008). Ubiquitination-mediated internalization and degradation of the astroglial glutamate transporter, GLT-1. Neurochem Int 53 : 296 308.
46. Sumners C, Tang W, Zelezna B, Raizada M (1991). Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Proc Natl Acad Sci USA 88 : 7567 7571.
47. Tamura Y, Sato Y, Akaike A, Shiomi H (1992). Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 592 : 317 325.
48. Thorlin T, Roginski R, Choudhury K, Nilsson M, Rönnbäck L, Hansson E et al. (1998). Regulation of the glial glutamate transporter GLT-1 by glutamate and delta-opioid receptor stimulation. FEBS Lett 425 : 453 459.
49. Timmermans P (1999). Pharmacological properties of angiotensin II receptor antagonists. Can J Cardiol 15 (Suppl. F 26F 28F.
50. Vermeiren C, Najimi M, Vanhoutte N, Tilleux S, de Hemptinne I, Maloteaux JM, et al 2005). Acute up-regulation of glutamate uptake mediated by mGluR5a in reactive astrocytes. J Neurochem 94 : 405 416.
51. Walther T, Olah L, Harms C, Maul B, Bader M, Hörtnagl H et al. (2002). Ischemic injury in experimental stroke depends on angiotensin II. FASEB J 16 : 169 176.
52. Wang P, Niidome T, Akaike A, Kihara T, Sugimoto H (2009). Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene. J Neurosci Res 87 : 2105 2114.
53. Weisinger R, Blair-West J, Burns P, Denton D, Tarjan E (1997). Role of brain angiotensin in thirst and sodium appetite of rats. Peptides 18 : 977 984. (Pubitemid 27489373)
54. Wright J, Yamamoto B, Harding J (2008). Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets. Prog Neurobiol 84 : 157 181.
55. Yang Y, Gozen O, Watkins A, Lorenzini I, Lepore A, Gao Y et al. (2009). Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1. Neuron 61 : 880 894.
56. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000). Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 : 145 153.
57. Zelenaia O, Schlag B, Gochenauer G, Ganel R, Song W, Beesley J et al. (2000). Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB. Mol Pharmacol 57 : 667 678.